OBWG
RXRX icon

Onyx Bridge Wealth Group’s Recursion Pharmaceuticals RXRX Stock Holding History

Onyx Bridge Wealth Group’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$70.5K Hold
19,200
– – 0.01% 379
2026
Q1 		$58.9K Buy
19,200
+2,000
+12% +$7.73K 0.01% 366
2025
Q4 		$70.3K Sell
17,200
-300
-2% -$1.49K 0.01% 358
2025
Q3 		$85.4K Buy
17,500
+6,000
+52% +$31.5K 0.01% 356
2025
Q2 		$58.2K Buy
+11,500
New +$56.5K 0.01% 309

Other funds holding RXRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $394M AUM 25.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Onyx Bridge Wealth Group's RXRX Position: Q2 2026 in Review

Onyx Bridge Wealth Group held its Recursion Pharmaceuticals (RXRX) position steady in Q2 2026 at 19,200 shares worth $70.5K. The position accounts for 0.01% of the portfolio, ranked #379.

Onyx Bridge Wealth Group first reported a position in RXRX in Q2 2025 and has held it in 5 quarters since. The position peaked at $85.4K in Q3 2025. 343 funds tracked by Wall St. Rank hold RXRX as of Q2 2026.

  • Onyx Bridge Wealth Group held 19,200 shares of Recursion Pharmaceuticals worth $70.5K as of Q2 2026.
  • Onyx Bridge Wealth Group left its Recursion Pharmaceuticals share count unchanged in Q2 2026.
  • Recursion Pharmaceuticals made up 0.01% of Onyx Bridge Wealth Group's portfolio in Q2 2026, its #379 holding.
  • Onyx Bridge Wealth Group first reported a position in Recursion Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • Onyx Bridge Wealth Group's Recursion Pharmaceuticals position peaked at $85.4K in Q3 2025.
  • 343 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q2 2026.

Based on Onyx Bridge Wealth Group's 13F filing for Q2 2026, filed 23 Jul 2026.